Relmada Therapeutics

RLMD

Market cap $294M

4.01 USD

-0.49

10.89%

At close Updated Dec 17, 4:00 PM EST

Pre-market

After hours

4.02

+0.01

0.25%

1 day

-10.89%

5 days

-8.86%

1 month

1.01%

3 months

165.56%

6 months

469.6%

Year to date

790.91%

1 year

1,008.65%

5 years

-88.55%

10 years

-63.41%

About: Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Employees: 17

Healthcare Biotechnology